Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]Metaiodobenzylguanidine myocardial scintigraphy

Circulation

Volumn 96, Issue 3, 1997, Pages 821-826

  Lanza, Gaetano Antonio ^a   Giordano, Alessandro ^a   Pristipino, Christian ^a   Calcagni, Maria Lucia ^a   Meduri, Guido ^a   Trani, Carlo ^a   Franceschini, Rodolfo ^b   Crea, Filippo ^a   Troncone, Luigi ^a   Maseri, Attilio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Cyberonics Inc   (Italy)

Author keywords

Nervous system, adrenergic; Scintigraphy; Syndrome X

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CATECHOLAMINE; THALLIUM 201;

ADRENERGIC NERVE; ADULT; ANGINA PECTORIS; ARTICLE; CATECHOLAMINE URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; HEART; HEART MUSCLE PERFUSION; HEART NERVE; HEART SCINTISCANNING; HUMAN; MALE; MEDIASTINUM; PRIORITY JOURNAL; REPRODUCIBILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYNDROME X;

EID: 0030756255     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.3.821     Document Type: Article

References (44)

1. Kemp HG, Vokonas PS, Cohn PF, Gorlin R. The anginal syndrome associated with normal coronary arteriograms. Am J Cardiol. 1973; 54:735-742.
2. Maseri A, Crea F, Kaski JC, Crake T. Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol. 1991;17:499-506.
3. Maseri A. Syndrome X and microvascular angina. In: Maseri A, ed. Ischemic Heart Disease: A Rational Basis for Clinical Practise and Clinical Research. New York, NY: Churchill Livingstone; 1995: 507-532.
4. Opherk D, Zebe H, Schuler G, Weihe E, Mall G, Kubler W. Reduced coronary dilator capacity and ultrastructural changes of the myocardium in patients with angina pectoris but normal coronary arteriograms. Circulation. 1981;63:817-825.
5. Cannon RO, Epstein SE. 'Microvascular angina' as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol. 1988;61:1338-1343.
6. Galassi AR, Crea F, Araujo LI, Lammertsma AA, Pupita G, Yamamoto Y, Rechavia E, Jones T, Kaski JC, Maseri A, Taylor C, Lewington G. Comparison of regional myocardial blood flow in syndrome X and one-vessel coronary artery disease. Am J Cardiol. 1993;72:134-139.
7. Chauhan A, Mullins PA, Petch MC, Schofield PM. Effect of hyperventilation and mental stress on coronary blood flow in syndrome X. Br Heart J. 1993;69:516-524.
8. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659-1664.
9. Chauhan A, Mullins PA, Petch MC, Schofield PM. Is coronary flow reserve in response to papaverine really abnormal in syndrome X? Circulation. 1994;89:1998-2004.
10. Cannon RO, Camici PG, Epstein SE. Pathophysiological dilemma of syndrome X. Circulation. 1992;85:883-892.
11. Nihoyannopoulos P, Kaski JC, Crake T, Maseri A. Absence of myocardial dysfunction during stress in patients with syndrome X. J Am Coll Cardiol. 1991;18:1463-1470.
12. Picano E, Lattanzi F, Masini M, Distante A, L'Abbate A. Usefulness of a high-dose dipyridamole-echocardiography test for diagnosis of syndrome X. Am J Cardiol. 1987;60:508-512.
13. Rosen SD, Uren NG, Kaski JC, Tousoulis D, Davies GJ, Camici PG. Coronary vasodilator reserve, pain perception, and sex in patients with syndrome X. Circulation. 1994;90:50-60.
14. Kaski JC, Rosano GMC, Collins P, Nihoyannopoulos P, Maseri A, Poole-Wilson PA. Cardiac syndrome X: clinical characteristics and left ventricular function: long-term follow-up study. J Am Coll Cardiol. 1995;25:807-814.
15. Galassi AR, Kaski JC, Crea F, Pupita G, Gavrielides S, Tousoullis D, Maseri A. Heart rate response during exercise testing and ambulatory ECG monitoring in patients with syndrome X. Am Heart J. 1991;122:458-463.
16. Montorsi P, Fabbiocchi F, Loaldi A, Fabbiocchi P, Polese A, De Cesare N, Guazzi MD. Coronary adrenergic hyperreactivity in patients with syndrome X and abnormal electrocardiogram at rest. Am J Cardiol. 1991;68:1698-1703.
17. Rosano GMC, Ponikowski P, Adamopoulos S, Collins P, Poole-Wilson PA, Coats AJS, Kaski JC. Abnormal autonomic control of the cardiovascular system in syndrome X. Am J Cardiol. 1994;73: 1174-1179.
18. Rosen SD, Dritsas A, Bourdillon PJ, Camici PG. Analysis of the electrocardiographic QT interval in patients with syndrome X. Am J Cardiol. 1994;73:971-972.
19. Meeder JG, Blanksma PK, Crijns HGJM, Anthonio RL, Pruim J, Brouwer J, de Jong RM, van der Wall EE, Vaalburg W, Lie KI. Mechanisms of angina pectoris in syndrome X assessed by myocardial perfusion dynamics and heart rate variability. Eur Heart J. 1995;16:1571-1577.
20. Feigl EO. Adrenergic control of transmural coronary blood flow. Basic Res Cardiol. 1990;85(suppl I):167-175.
21. Krajcar M, Heusch G. Local and neurohumoral control of coronary blood flow. Basic Res Cardiol. 1990;85(suppl I):25-42.
22. Cordero DL, Cagin NA, Natelson BH. Neurocardiology update: role of the nervous system in coronary vasomotion. Cardiovasc Res. 1995;29:319-328.
23. Camici PG, Marracini P, Gistri R, Salvadori PA, Sorace O, L'Abbate A. Adrenergically mediated coronary vasoconstriction in patients with syndrome X. Cardiovasc Drugs Ther. 1994;8:221-226.
24. Sisson JC, Shapiro B, Meyers L, Mallette S, Mangner TJ, Wieland TM, Glowniak JV, Sherman P, Beierwaltes WH. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med. 1987;28:1625-1636.
25. Wafelman AR, Hoefnagel CA, Maes RAA, Beijnen JH. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions and dosimetry. Eur J Nucl Med. 1994;21:545-559.
26. Solanki KK, Bomanji J, Moyes J, Mather SJ, Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodo benzylguanidine (MIBG). Nucl Med Commun. 1992;13:513-521.
27. 123I]MIBG to assess cardiac adrenergic innervation: experience in hypertensive cardiopathy and left ventricular aneurysm. Q J Nucl Med. 1995;39(suppl 1):44-48.
28. Nakajo M, Shimabukuro K, Yoshimura H, Yonekura R, Nakabeppu Y, Tanoue P, Shinohara S. Iodine-131 metaiodobenzylguanidine intra- and extravascular accumulation in the rat heart. J Nucl Med. 1986;27:84-89.
29. Merlet P, Valette H, Randé JD, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D, Loisance D, Castaigne A, Syrota A. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
30. Glowniak JV, Turner FE, Gray LL, Palac RT, Lagunas-Solar MC, Woodward WR. Iodine-123 metaiodobenzylguanidine imaging of the heart in idiopathic congestive cardiomyopathy and cardiac transplants. J Nucl Med. 1989;30:1182-1191.
31. Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, Beierwaltes W. Myocardial imaging in man with I-123 metaiodobenzylguanidine. J Nucl Med. 1981;22:129-132.
32. Wieland TM, Brown LE, Rogers L, Worthington KC, Wu J, Clinthorne NH, Otto CA, Swanson DP, Beierwaltes WH. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med. 1981;22:22-31.
33. Minardo JD, Tuli MM, Mock BH, Weiner RE, Pride HP, Wellman HN, Zipes DP. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation. 1988;78:1008-1019.
34. Iwasaki T, Suzuki T, Tateno M, Sasaki Y, Oshima S, Imai S. Dual-tracer autoradiography with thallium-201 and iodine-125-metaiodobenzylguanidine in experimental myocardial infarction of rat. J Nucl Med. 1996;37:680-684.
35. McGhie AI, Corbett JR, Akers MS, Kulkarni P, Sills MN, Kremers M, Buja M, Durant-Reville M, Parkey RW, Willerson TJ. Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol. 1991;67:236-242.
36. Dae MW, Herre JM, O'Connell JW, Botvinick EH, Newman D, Munoz L. Scintigraphic assessment of sympathetic innervation after transmural versus nontransmural myocardial infarction. J Am Coll Cardiol. 1991;17:1416-1423.
37. Tomoda H, Yoshioka K, Shiina Y, Tagawa R, Ide M, Suzuki Y. Regional sympathetic denervation detected by iodine 123 metaiodobenzylguanidine in non-Q-wave myocardial infarction and unstable angina. Am Heart J. 1994;128:452-458.
38. Hartikainen J, Mantysaari M, Kuikka J, Lansimies E, Pyorala K. Extent of cardiac autonomic denervation in relation to angina on exercise test in patients with recent acute myocardial infarction. Am J Cardiol. 1994;74:760-763.
39. Hartikainen J, Kuikka J, Mantysaari M, Lansimies E, Pyorala K. Sympathetic reinnervation after acute myocardial infarction. Am J Cardiol. 1996;77:5-9.
40. De Marco T, Dae M, Yuen-Gree MSF, Kumar S, Sudhir K, Keith F, Amidon TM, Rifkin C, Klinski C, Lau D, Botvinick EH, Chatterjee K. Iodine-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J Am Coll Cardiol. 1995;25:927-931.
41. Imamura Y, Ando H, Mitsuoka W, Egashira S, Masaki H, Ashihara T, Fukuyama T. Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause. J Am Coll Cardiol. 1995;26:1594-1599.
42. Tsutsui H, Ando S, Fukai T, Kuroiwa M, Egashira K, Sasaki M, Kuwabara Y, Koyanagi S, Takeshita A. Detection of angina-provoking coronary stenosis by resting iodine 123 metaiodobenzylguanidine scintigraphy in patients with unstable angina pectoris. Am Heart J. 1995;129:708-715.
43. Nakata T, Nagao K, Tsuchihashi K, Hashimoto A, Tanaka S, Iimura O. Regional cardiac sympathetic nerve dysfunction and the diagnostic efficacy of metaiodobenzylguanidine in stable coronary artery disease. Am J Cardiol. 1996;78:292-297.
44. Takano H, Nakamura T, Satou T, Umetani K, Watanabe A, Ishihara T, Mochizuchi S, Kimura H, Honma H, Ikeda Y, Koizumi K, Arbab AS, Tamura K. Regional myocardial sympathetic dysinnervation in patients with coronary vasospasm. Am J Cardiol. 1995;75:324-329.